Lessons from COVID-19 - Building a more resilient response for the next pandemic - Health System and Drug Development perspectives

Abstract

This paper evaluates the challenges faced by the healthcare systems and the drug-development industry in responding to the COVID-19 pandemic. We explore the role of key stakeholders and different healthcare models that can help ensure a robust pandemic response. In drug-development, we scrutinize the challenges linked with COVID-19 antivirals, vaccines, and antibodies and explore the potential of repurposing existing therapeutics through the use of advanced technologies while predicting clinical trial outcomes. We consider the intricacies of manufacturing, regulatory, and funding factors in vaccine preparedness. We conclude by exploring the future of pandemic preparedness, highlighting rapid innovation, and the potential for accelerated drug discovery as powerful tools in addressing the next pandemic.